Protagonist Therapeutics
PTGX
PTGX
66 hedge funds and large institutions have $93.2M invested in Protagonist Therapeutics in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
+5
Holders Change %
+8.2%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
15
Reduced
31
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VMI
VHCP Management III
New York
|
+$2.85M |
| 2 |
VMI
VHCP Management II
New York
|
+$1.68M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.15M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$870K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$823K |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$6.59M |
| 2 |
Jennison Associates
New York
|
-$3.6M |
| 3 |
Millennium Management
New York
|
-$2.31M |
| 4 |
Renaissance Technologies
New York
|
-$1.33M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$878K |
